Request to Join
has invited you to join this group
Discussions
There are currently no active discussions.
Please check out
our archive of past discussions.
Upcoming Discussions
-
Less than
1 day
left
LeftBegins in
less than
1 day
Begins in
Ended
Ongoing
FollowThis discussion will focus on patients with HPV-positive OPSCC who are eligible to receive a de-escalation therapy.
-
Moderators
-
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramNabil Saba
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramProfessor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
-
Experts
-
Assistant Professor at Emory UniversityConor Steuer, MD
Assistant Professor at Emory UniversityAssistant Professor at Emory University
-
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of BirminghamHisham Mehanna
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of Birmingham
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of Birmingham
-
-
Less than
1 day
left
LeftBegins in
less than
1 day
Begins in
Ended
Ongoing
FollowThis discussion centers on using checkpoint inhibitors to manage squamous cell carcinoma of the head and neck (SCCHN).
-
Moderators
-
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramNabil Saba
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
-
Experts
-
Associate Director, Moore Cancer Center; Professor of MedicineEzra Cohen
Associate Director, Moore Cancer Center; Professor of MedicineAssociate Director, Moore Cancer Center; Professor of Medicine
-
Google
